Review
doi: 10.1086/519432.
Epub 2007 Jun 18.
The influence of hormonal contraceptive use on HIV-1 transmission and disease progression
Affiliations
- PMID: 17599316
- DOI: 10.1086/519432
Item in Clipboard
Review
The influence of hormonal contraceptive use on HIV-1 transmission and disease progression
Clin Infect Dis.
.
Abstract
Women account for nearly one-half of new human immunodeficiency virus type 1 (HIV-1) infections worldwide, including the majority of infections in Africa. Biological and epidemiological studies suggest that hormonal contraceptive use could influence susceptibility to HIV-1, as well as infectivity and disease progression for those who become infected. However, not all studies have shown this relationship, and many questions remain. Safe and effective contraceptive choices are essential for women with and at risk for HIV-1 infection. Thus, understanding the effect, if any, of hormonal contraception on HIV-1 disease among women is a public health priority.
Similar articles
-
Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV.MMWR Morb Mortal Wkly Rep. 2012 Jun 22;61(24):449-52. MMWR Morb Mortal Wkly Rep. 2012. PMID: 22717514
-
Heterosexual transmission of human immunodeficiency virus type 1 (HIV): interactions of conventional sexually transmitted diseases, hormonal contraception and HIV-1.AIDS Res Hum Retroviruses. 1998 Apr;14 Suppl 1:S5-10. AIDS Res Hum Retroviruses. 1998. PMID: 9581877 Review.
-
Women, contraception and STDs including HIV.Int J STD AIDS. 1995 Nov-Dec;6(6):373-86. doi: 10.1177/095646249500600601. Int J STD AIDS. 1995. PMID: 8845393 Review.
-
HIV/AIDS in women: an expanding epidemic.Science. 2005 Jun 10;308(5728):1582-3. doi: 10.1126/science.1112489. Science. 2005. PMID: 15947174 Review.
-
Natural history and risk factors associated with early and established HIV type 1 infection among reproductive-age women in Malawi.Clin Infect Dis. 2008 Jun 15;46(12):1913-20. doi: 10.1086/588478. Clin Infect Dis. 2008. PMID: 18462100 Clinical Trial.
Cited by
-
Depo-provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus.PLoS One. 2010 Mar 23;5(3):e9814. doi: 10.1371/journal.pone.0009814. PLoS One. 2010. PMID: 20352116 Free PMC article.
-
Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women.Contraception. 2018 Apr;97(4):357-362. doi: 10.1016/j.contraception.2018.01.011. Epub 2018 Feb 17. Contraception. 2018. PMID: 29408422 Free PMC article.
-
Female Sex Hormones Upregulate the Replication Activity of HIV-1 Sub-Subtype A6 and CRF02_AG but Not HIV-1 Subtype B.Pathogens. 2023 Jun 27;12(7):880. doi: 10.3390/pathogens12070880. Pathogens. 2023. PMID: 37513727 Free PMC article.
-
A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle.AIDS. 2008 Oct 1;22(15):1909-17. doi: 10.1097/QAD.0b013e3283060ea4. AIDS. 2008. PMID: 18784454 Free PMC article. Review. No abstract available.
-
Hormonal contraception, sexual behaviour and HIV prevalence among women in Cameroon.BMC Womens Health. 2008 Oct 30;8:19. doi: 10.1186/1472-6874-8-19. BMC Womens Health. 2008. PMID: 18973697 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
